Caligan Partners LP Q4 2024 Filing
Filed February 14, 2025
Portfolio Value
$394.9B
Holdings
14
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (14 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | LQDALIQUIDIA CORPORATION | 8,118,592 | $115.5B | 29.26% | |
| 2 | VRNAVERONA PHARMA PLC | 1,436,878 | $66.7B | 16.90% | |
| 3 | EX9EXELIXIS INC | 1,525,730 | $50.8B | 12.87% | |
| 4 | EOLSEVOLUS INC | 2,692,388 | $29.7B | 7.53% | |
| 5 | ANIKANIKA THERAPEUTICS INC | 1,435,130 | $23.6B | 5.98% | |
| 6 | BCRXBIOCRYST PHARMACEUTICALS INC | 2,995,932 | $22.5B | 5.71% | |
| 7 | AGIOAGIOS PHARMACEUTICALS INC | 626,280 | $20.6B | 5.21% | |
| 8 | SG7SAGE THERAPEUTICS INC | 3,052,538 | $16.6B | 4.20% | |
| 9 | YMABUSDY-MABS THERAPEUTICS INC | 1,767,982 | $13.8B | 3.51% | |
| 10 | MLYSMINERALYS THERAPEUTICS INC | 1,011,155 | $12.4B | 3.15% | |
| 11 | MRUSMERUS N V | 255,000 | $10.7B | 2.72% | |
| 12 | ABVXABIVAX SA | 752,167 | $5.5B | 1.39% | |
| 13 | VRCAVERRICA PHARMACEUTICALS INC | 7,429,687 | $5.2B | 1.32% | |
| 14 | ENTAENANTA PHARMACEUTICALS INC | 184,826 | $1.1B | 0.27% |